Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Di | Xebra Brands Ltd (2): Xebra Brands strikes partnership for U.S. CBD launch | 2 | Stockwatch | ||
Di | Xebra Brands Ltd: Xebra Brands Executes Manufacturing and Distribution Agreement to Launch CBD Product Line in the U.S. | 155 | ACCESS Newswire | VANCOUVER, BC / ACCESS Newswire / April 15, 2025 / Xebra Brands Ltd. ("Xebra" or the "Company") (CSE:XBRA)(OTCQB:XBRAF)(FSE:9YC0), a leading innovator in the North American cannabis sector, is pleased... ► Artikel lesen | |
10.04. | Xebra Brands Ltd (2): Xebra calls out for partners of all stripe in Mexico | 3 | Stockwatch | ||
XEBRA BRANDS Aktie jetzt für 0€ handeln | |||||
10.04. | Xebra Brands Ltd: Xebra Brands Launches National RFP to Establish Cannabis Cultivation Partnerships Across Mexico | 214 | ACCESS Newswire | VANCOUVER, BC / ACCESS Newswire / April 10, 2025 / Xebra Brands Ltd. ("Xebra" or the "Company") (CSE:XBRA)(OTCQB:XBRAF)(FSE:9YC0), a trailblazer in the Mexican cannabis sector and the sole company legally... ► Artikel lesen | |
08.04. | Xebra Brands Ltd (2): Xebra talks North American focus amid tariff talk | 2 | Stockwatch | ||
08.04. | Xebra Brands touts tariff resilience | 1 | The Market Herald Canada | ||
08.04. | Xebra Brands Ltd: Xebra Brands Reaffirms North American Strategy Following U.S. Tariff Clarity | 142 | ACCESS Newswire | VANCOUVER, BC / ACCESS Newswire / April 8, 2025 / Xebra Brands Ltd. ("Xebra" or the "Company") (CSE:XBRA)(OTCQB:XBRAF)(FSE:9YC0), a leading innovator in the Mexican cannabis sector and the only company... ► Artikel lesen | |
03.04. | Xebra Brands Ltd (2): Xebra Brands backer Diaz adds a million shares | 2 | Stockwatch | ||
03.04. | Xebra Brands Ltd: Xebra Brands' Largest Shareholder Increases Stake as Company Explores Landmark Agricultural Agreement in Mexico | 121 | ACCESS Newswire | VANCOUVER, BC / ACCESS Newswire / April 3, 2025 / Xebra Brands Ltd. ("Xebra" or the "Company") (CSE:XBRA)(OTCQB:XBRAF)(FSE:9YC0), a trailblazer in the Mexican cannabis sector and the sole company legally... ► Artikel lesen | |
26.03. | Xebra Brands Ltd (2): Xebra expands partnership to launch Elements products | 4 | Stockwatch | ||
26.03. | Xebra Brands Ltd: BSK Holdings Inc and Xebra Expand Partnership to Launch Elements Products in the United States | 268 | ACCESS Newswire | VANCOUVER, BC / ACCESS Newswire / March 26, 2025 / Xebra Brands Ltd. ("Xebra" or the "Company") (CSE:XBRA)(OTCQB:XBRAF)(FSE:9YC0), a pioneer in the Mexican cannabis market and exclusive holder of cannabis... ► Artikel lesen | |
25.03. | Xebra Brands Ltd (2): Xebra evaluating commercial opportunities in Europe | 1 | Stockwatch | ||
25.03. | Xebra Brands weighs opportunities after scoring Dutch cannabis license | 3 | The Market Herald Canada | ||
25.03. | Xebra Brands Ltd: Xebra Brands Evaluates Strategic Opportunities Following Award of Dutch Cannabis License | 389 | ACCESS Newswire | VANCOUVER, BC / ACCESS Newswire / March 25, 2025 / Xebra Brands Ltd. ("Xebra" or the "Company") (CSE:XBRA)(OTCQB:XBRAF)(FSE:9YC0), a trailblazer in the Mexican cannabis sector and the sole company legally... ► Artikel lesen | |
19.03. | Xebra Brands Ltd (2): Xebra Brands enters partnership for Mexican market | 1 | Stockwatch | ||
19.03. | Xebra Brands Ltd: Xebra Brands Announces Partnership with BSK Holdings Inc to Launch CBD Products | 203 | ACCESS Newswire | VANCOUVER, BC / ACCESS Newswire / March 19, 2025 / Xebra Brands Ltd. ("Xebra" or the "Company") (CSE:XBRA)(OTCQB:XBRAF)(FSE:9YC0), a trailblazer in the Mexican cannabis sector and the sole company legally... ► Artikel lesen | |
27.02. | Xebra Brands Ltd: Xebra Brands Acknowledges COFEPRIS Announcement, Marking a Major Turning Point in Mexico's Cannabis Industry | 260 | ACCESS Newswire | VANCOUVER, BC / ACCESS Newswire / February 27, 2025 / Xebra Brands Ltd. ("Xebra" or the "Company"), (CSE:XBRA)(OTCQB:XBRAF)(FSE:9YC0) a trailblazer in the Mexican cannabis industry, welcomes the latest... ► Artikel lesen | |
26.02. | Xebra Brands Ltd (2): Xebra Brands details plans for 2025 | 2 | Stockwatch | ||
25.02. | Xebra Brands Ltd: Xebra Brands Unveils Strategic 2025 Roadmap to Accelerate Growth in North American CBD Market | 665 | ACCESS Newswire | VANCOUVER, BC / ACCESS Newswire / February 25, 2025 / Xebra Brands Ltd. ("Xebra" or the "Company") (CSE:XBRA)(OTCQB:XBRAF)(FSE:9YC0) is pleased to announce the development of the Strategic 2025 Roadmap... ► Artikel lesen | |
13.02. | Xebra Brands Ltd (2): Xebra Brands closes $448,146 shares for debt deal | 2 | Stockwatch |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
BAYER | 21,030 | +0,36 % | Bayer-Aktie: Der Bewertungstrick! | News von Trading-Treff.de Bayer hat am Mittwoch mit dem Gewinn von 0,05 % die Börsensitzung recht bescheiden eröffnet. Der Kurs bleibt bei über 20 Euro und nahm nun 20,84 Euro ein. Dennoch ist und verharrt... ► Artikel lesen | |
AURORA CANNABIS | 3,860 | -1,28 % | Aurora Cannabis Inc (3): Aurora Cannabis offers inhalers to U.K. patients | ||
CANOPY GROWTH | 1,052 | +0,77 % | Canopy Growth-Aktie: Gleich zwei neue Gefahren | Die Kursentwicklung der Canopy Growth-Aktie ist seit langer Zeit ein einziges Trauerspiel. In den letzten zwölf Monaten lösten sich 90% des Unternehmenswertes in Luft auf und seit einer Woche notiert... ► Artikel lesen | |
TILRAY BRANDS | 0,400 | +0,78 % | Tilray Brands, Inc.: Tilray Brands Announces Proposed Reverse Stock Split and Corresponding Special Meeting of Stockholders | NEW YORK and LEAMINGTON, Ontario, April 17, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or "Company") (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at... ► Artikel lesen | |
INNOCAN PHARMA | 0,112 | +2,29 % | InnoCan Pharma Aktie: Leichte Erholung nach Talfahrt | InnoCan Pharma verzeichnet leichten Aufwärtstrend, bleibt aber mit deutlichen Verlusten konfrontiert. Wie nachhaltig ist die aktuelle Erholung? Die InnoCan Pharma Aktie hat am Dienstag eine kleine Gegenbewegung... ► Artikel lesen | |
CRONOS GROUP | 1,523 | -1,81 % | Cronos Group Inc.: Cronos Appoints Anna Shlimak as Chief Financial Officer | TORONTO, March 19, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) ("Cronos" or the "Company"), an innovative global cannabinoid company, today announced the appointment of Anna... ► Artikel lesen | |
SYNBIOTIC | 3,210 | -3,02 % | EQS-Adhoc: SYNBIOTIC SE: Strategische Partnerschaft mit IRIS Capital Investment | EQS-Ad-hoc: SYNBIOTIC SE / Schlagwort(e): Kapitalmaßnahme/Finanzierung
SYNBIOTIC SE: STRATEGISCHE PARTNERSCHAFT MIT IRIS CAPITAL INVESTMENT
17.04.2025 / 13:21 CET/CEST
Veröffentlichung... ► Artikel lesen | |
NEKTAR THERAPEUTICS | 0,576 | +2,67 % | Nektar Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results | SAN FRANCISCO, March 12, 2025 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today reported financial results for the fourth quarter ended December 31, 2024.
Cash... ► Artikel lesen | |
ORAMED PHARMACEUTICALS | 1,904 | -1,42 % | Oramed Aktie: Besorgniserregende Signale? | Die Oramed Pharmaceuticals Aktie verzeichnete am 22. Februar 2025 einen signifikanten Rückgang. Der Aktienkurs fiel um 3,15 Prozent auf 2,15 USD, was einem Minus von 0,07 USD gegenüber dem vorherigen... ► Artikel lesen | |
OPKO HEALTH | 1,234 | -1,53 % | Entera Bio Ltd.: OPKO Health and Entera Bio Enter into Collaboration Agreement to Advance Oral GLP-1/Glucagon Tablet Candidate into the Clinic to Treat Obesity and Metabolic Disorders | MIAMI and JERUSALEM, March 17, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) and Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of oral peptides and proteins replacement therapies... ► Artikel lesen | |
JAGUAR HEALTH | 5,630 | +2,18 % | Jaguar Health, Inc.: Proof-of-Concept Data for Rare Disease Indications MVID and SBS-IF for Jaguar Health's Crofelemer to be Presented at April 2025 ELITE PED-GI Congress | Crofelemer, a novel plant-based anti-secretory prescription drug, has been granted Orphan Drug Designation by the FDA and the European Medicines Agency (EMA) for both short bowel syndrome (SBS) and... ► Artikel lesen | |
SELLAS LIFE SCIENCES | 1,180 | +3,51 % | SELLAS Life Sciences Group, Inc.: SELLAS Announces Positive Overall Survival in Cohort 3 from the Ongoing Phase 2 Trial of SLS009 in r/r AML | - 8.9 Months Median Overall Survival (mOS) in Patients with AML-Myelodysplasia-Related Changes (AML-MRC) and 8.8 mOS in All Relapsed or Refractory to Venetoclax-Based Regimens Patients; Surpassing... ► Artikel lesen | |
XORTX THERAPEUTICS | 0,790 | -2,95 % | XORTX Therapeutics Inc.: XORTX Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency | CALGARY, Alberta, April 17, 2025 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the "Company") (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late stage clinical pharmaceutical company focused... ► Artikel lesen | |
NUMINUS WELLNESS | 0,027 | -100,00 % | XFRA LR23: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILNUMINUS WELLNESS... ► Artikel lesen | |
CANNOVUM CANNABIS | 0,301 | +30,87 % | EQS-News: Cannovum Cannabis AG: Abwicklung bzw. Veräußerung der Beteiligungen im Cannabis-Bereich | EQS-News: Cannovum Cannabis AG
/ Schlagwort(e): Strategische Unternehmensentscheidung/Sonstiges
Cannovum Cannabis AG: Abwicklung bzw. Veräußerung der Beteiligungen im Cannabis-Bereich... ► Artikel lesen |